November 10, 2022

Press release - Non-regulatory

Hubro Therapeutics AS acquires GM-CSF vaccine adjuvant from Targovax ASA in asset purchase agreement

October 20, 2022

Press release - Non-regulatory

The ONCOS-102 phase 1b melanoma study is published in the prestigious scientific journal Clinical Cancer Research – with updated publication info

October 20, 2022

Press release - Non-regulatory

The ONCOS-102 phase 1b melanoma study is published in the prestigious scientific journal Clinical Cancer Research

October 5, 2022

Press release - Non-regulatory

The ONCOS-102 phase 1b melanoma study selected for oral presentation at the SITC 2022 annual meeting

September 27, 2022

Press release - Non-regulatory

Targovax receives approval to proceed with the ONCOS-102 phase 2 melanoma study from the US FDA

September 26, 2022

Press release - Non-regulatory

Reminder: Targovax to host Investor Event 27 September

September 19, 2022

Press release - Non-regulatory

Targovax to host Investor Event: Meet the Management on 27 September

September 12, 2022

Press release - Non-regulatory

Targovax to present at upcoming conferences

August 11, 2022

Press release - Non-regulatory

Targovax ASA: Invitation to Targovax’s second quarter and first half 2022 presentation, Thursday 18 August

June 23, 2022

Press release - Non-regulatory

Targovax announces that the FDA has granted authorization to initiate clinical trials with the enhanced TG01 RAS vaccine in the USA

May 27, 2022

Press release - Non-regulatory

Targovax announces publication of the two abstracts accepted for poster presentation at ASCO 2022

May 11, 2022

Press release - Non-regulatory

Targovax to present at upcoming conferences

May 10, 2022

Press release - Non-regulatory

Targovax and Oslo University Hospital announce collaboration to test TG mutant RAS vaccination in multiple myeloma

May 3, 2022

Press release - Non-regulatory

Targovax ASA: Invitation to presentation of Targovax’s first quarter 2022 results, Thursday 12 May

April 28, 2022

Press release - Non-regulatory

Targovax ASA: Two ONCOS-102 abstracts accepted for ASCO

April 26, 2022

Press release - Non-regulatory

Targovax to present at 5th Neoantigen Summit Europe in Amsterdam

April 21, 2022

Press release - Non-regulatory

Targovax ASA announces the appointment of two new Board Directors

March 9, 2022

Press release - Non-regulatory

Targovax ASA: Poster presentation at the AACR Annual Meeting

March 7, 2022

Press release - Non-regulatory

Targovax ASA and Agenus announce collaboration on mutant KRAS cancer vaccine adjuvanted with QS-21 STIMULON™

January 17, 2022

Press release - Non-regulatory

Targovax granted Patents for ONCOS-102 in combination with chemotherapy in China and Japan